Morgan Stanley Remains Positive On Stryker Corporation

In a report published Thursday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating and $91.00 price target on

. In the report, Morgan Stanley noted, “We approached the analyst day looking for a commitment to leverage and improving M&A returns and left mostly satisfied. There was no commentary on SNN given UK takeover rules, but we remain unconvinced SNN can drive appropriate returns for shareholders at this time.” Stryker Corporation closed on Wednesday at $83.94.